Trial
NCT01483872
Use of a Novel Catheter Lock Solution For Treatment of Hemodialysis Catheter Infections
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, San Diego
Collaborators
—
Condition
Infection
Intervention
NAC/Tigecycline/Heparin combination lock solution
Why stopped
The study was stopped due to poor enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-06